Induction Treatment With Low-Dose Thymoglobulin or Basiliximab in Renal Transplants From Older Donors

Transplantation Proceedings

Volumn 40, Issue 9, 2008, Pages 2900-2902

  Gavela Martinez E ^a   Sancho Calabuig, A ^a   Escudero Quesada, V ^a   Avila Bernabeu A I ^a   Beltran Catalan S ^a   Morales Garcia A I ^a   Crespo Albiach, J F ^a   Pallardo Mateu L M ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CREATININE; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AGED; AGING; ARTICLE; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; ORGAN DONOR; PRIORITY JOURNAL; PROPHYLAXIS;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; CREATININE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECOMBINANT FUSION PROTEINS; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 55749086183     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.08.082     Document Type: Article

References (8)

1. Arns W., Citterio F., and Campistol J.M. 'Old-for-old'-new strategies for renal transplantation. Nephrol Dial Transplant 22 (2007) 336
2. Ojo A.O., Wolfe R.A., Held P.J., et al. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 63 (1997) 968
3. Mourad G., Rostaing L., Legendre C., et al. Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids. Transplantation 78 (2004) 584
4. Sollinger H., Kaplan B., Pescovitz M.D., et al. Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection. Transplantation 72 (2001) 1915
5. Kaden J., May G., Mueller P., et al. Lymphomas after solid organ transplantation: a collaborative study report. Am J Transplant 4 (2004) 222
6. Brennan D.C., Daller J.A., Lake K.D., et al. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 355 (2006) 1967
7. Kylonen L.E., Eklund B.H., Pesonen E.J., et al. Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression: efficacy and safety. Transplantation 84 (2007) 75
8. Hernández D., Miguel R., Porrini E., et al. Randomized controlled study comparing reduced calcineurin inhibitor exposure versus standard cyclosporine-based immunosuppression. Transplantation 84 (2007) 706